179 related articles for article (PubMed ID: 37830399)
1. A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
Fujisaki M; Kasamatsu H; Nishimura K; Yoshida Y; Muneishi Y; Yamaguchi T; Nishino I; Konishi R; Ichimura Y; Okiyama N; Oyama N; Hasegawa M
J Dermatol; 2024 Feb; 51(2):301-306. PubMed ID: 37830399
[TBL] [Abstract][Full Text] [Related]
2. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
[TBL] [Abstract][Full Text] [Related]
3. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
[TBL] [Abstract][Full Text] [Related]
4. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
[TBL] [Abstract][Full Text] [Related]
5. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
[TBL] [Abstract][Full Text] [Related]
6. Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody.
Kishida D; Ushiyama S; Shimojima Y; Ueno KI; Kurashina JI; Shirai T; Sekijima Y
Intern Med; 2021 Aug; 60(16):2697-2700. PubMed ID: 33678748
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.
Peterson LK; Jaskowski TD; La'ulu SL; Tebo AE
Immunol Res; 2018 Jun; 66(3):431-436. PubMed ID: 29845587
[TBL] [Abstract][Full Text] [Related]
8. New-onset dermatomyositis following COVID-19: A case report.
Shimizu H; Matsumoto H; Sasajima T; Suzuki T; Okubo Y; Fujita Y; Temmoku J; Yoshida S; Asano T; Ohira H; Ejiri Y; Migita K
Front Immunol; 2022; 13():1002329. PubMed ID: 36353621
[TBL] [Abstract][Full Text] [Related]
9. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
[TBL] [Abstract][Full Text] [Related]
10. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
[TBL] [Abstract][Full Text] [Related]
11. Eyelid erythema as the first manifestation of subcutaneous panniculitis-like T-cell lymphoma mimicking dermatomyositis: a case-based review.
Sun X; Ji L; Li G; Nong L; Zhang W; Xie W; Zhang Z
Clin Rheumatol; 2022 Mar; 41(3):929-934. PubMed ID: 34786628
[TBL] [Abstract][Full Text] [Related]
12. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
14. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
Wolstencroft PW; Fiorentino DF
Curr Rheumatol Rep; 2018 Apr; 20(5):28. PubMed ID: 29637414
[TBL] [Abstract][Full Text] [Related]
15. Management of Myositis-Associated Interstitial Lung Disease.
Fujisawa T
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33916864
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
Muro Y; Sugiura K; Akiyama M
Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
[TBL] [Abstract][Full Text] [Related]
17. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.
Ge Y; Lu X; Shu X; Peng Q; Wang G
Sci Rep; 2017 Mar; 7(1):188. PubMed ID: 28298642
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Dermatomyositis and Immune-Mediated Necrotizing Myopathy with Poor Muscle Recovery with Steroids and IVIg: Therapeutic Strategies for Refractory Inflammatory Myositis].
Tomimitsu H
Brain Nerve; 2022 May; 74(5):545-552. PubMed ID: 35589645
[TBL] [Abstract][Full Text] [Related]
20. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
He L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
